Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 15 of 44
2021-07-21 [p.1254]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-613, P.C. 2021-614, P.C. 2021-615 and P.C. 2021-665 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-15. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-06-07 [p.1052]
— by Ms. Hajdu (Minister of Health) — Interim Order Respecting Ultraviolet Radiation-emitting Devices and Ozone-generating Devices, pursuant to the Pest Control Products Act, S.C. 2002, c. 28, ss. 67.1(6) and (7). — Sessional Paper No. 8560-432-1275-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-06-03 [p.1035]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-419, P.C. 2021-420 and P.C. 2021-421 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-14. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-06-01 [p.1014]
The order was read for the consideration of the business of supply.
Mr. Chong (Wellington—Halton Hills), seconded by Mr. Deltell (Louis-Saint-Laurent), moved, — That an order of the House do issue for the unredacted version of all documents produced by the Public Health Agency of Canada in response to the March 31, 2021, and May 10, 2021, orders of the Special Committee on Canada-China Relations, respecting the transfer of Ebola and Henipah viruses to the Wuhan Institute of Virology in March 2019, and the subsequent revocation of security clearances for, and termination of the employment of, Dr. Xiangguo Qiu and Dr. Keding Cheng, provided that:
(a) these documents shall be deposited with the Law Clerk and Parliamentary Counsel, in both official languages, within 48 hours of the adoption of this order;
(b) the Law Clerk and Parliamentary Counsel shall promptly thereafter notify the Speaker, who shall forthwith inform the House, whether he is satisfied the documents were produced as ordered;
(c) the Minister of Health shall be ordered to appear before the special committee, for at least three hours, at a televised meeting, to be held within two weeks of the adoption of this order, to discuss the documents and the matters referred to in them;
(d) the Law Clerk and Parliamentary Counsel shall confidentially review the documents with a view to redacting information which, in his opinion, could reasonably be expected to compromise national security or reveal details of an ongoing criminal investigation, other than the existence of an investigation;
(e) the Speaker shall cause the documents, as redacted pursuant to paragraph (d), to be laid upon the table at the next earliest opportunity and, after being tabled, they shall stand referred to the special committee;
(f) the Law Clerk and Parliamentary Counsel shall discuss with the special committee, at an in camera meeting, to be held within two weeks of the documents being tabled pursuant to paragraph (e), what information he redacted pursuant to paragraph (d); and
(g) the special committee may, after hearing from the Law Clerk and Parliamentary Counsel pursuant to paragraph (f), decide to make public any of the information which was redacted, as well as, in lieu of making such information public, rely on such information for the purpose of making findings and recommendations in any subsequent report to the House, provided that, for the purpose of this paragraph, the documents deposited pursuant to paragraph (a) shall be deemed to have been referred to the special committee.
Debate arose thereon.
2021-05-05 [p.902]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-313, P.C. 2021-314 and P.C. 2021-315 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-13. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-05-03 [p.882]
— by Ms. Hajdu (Minister of Health) — Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs relating to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-432-1018-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-04-27 [p.845]
Ms. Hajdu (Minister of Health) gave notice of intention to move at the next sitting of the House, pursuant to Standing Order 57, that, in relation to the consideration of Government Business No. 5, the debate not be further adjourned.
2021-03-26 [p.728]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-173 and P.C. 2021-174 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-12. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-03-22 [p.667]
— by Ms. Hajdu (Minister of Health) — Report of the Patented Medicine Prices Review Board for the year ended December 31, 2019, pursuant to the Patent Act, R.S., 1985, c. P-4, sbs. 89(4) and 100(4). — Sessional Paper No. 8560-432-564-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-03-08 [p.607]
— by Ms. Hajdu (Minister of Health) — Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in relation to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-432-1018-04. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-03-08 [p.608]
— by Ms. Hajdu (Minister of Health) — Interim Order No. 2 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, pursuant to the Food and Drugs Act, R.S. 1985, c. F-27, sbs. 30.1(6) and (7). — Sessional Paper No. 8560-432-1018-05. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-02-26 [p.600]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-75, P.C. 2021-76 and P.C. 2021-77 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-11. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-02-22 [p.559]
— by Ms. Hajdu (Minister of Health) — Report on the administration and operation of the Canada Health Act for the fiscal year ended March 31, 2020, pursuant to the Canada Health Act, R.S. 1985, c. C-6, s. 23. — Sessional Paper No. 8560-432-458-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
2021-02-18 [p.546]
— by Ms. Hajdu (Minister of Health) — Report of the Pest Management Regulatory Agency on the administration and enforcement of the Pest Control Products Act for the fiscal year ended March 31, 2020, pursuant to the Pest Control Products Act, S.C. 2002, c. 28, sbs. 80(1). — Sessional Paper No. 8560-432-991-01. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Agriculture and Agri-Food)
2021-02-03 [p.503]
— by Ms. Hajdu (Minister of Health) — Copies of Orders in Council P.C. 2021-9, P.C. 2021-10 and P.C. 2021-11 concerning minimizing the risk of exposure to COVID-19 in Canada, pursuant to the Quarantine Act, S.C. 2005, c. 20, sbs. 61(2). — Sessional Paper No. 8560-432-1079-10. (Pursuant to Standing Order 32(5), permanently referred to the Standing Committee on Health)
Results: 1 - 15 of 44 | Page: 1 of 3

1
2
3
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data